LRRK2 and Parkinson disease: It is well demonstrated that PD genes, including between others, SNCA and LRRK2, are expressed in microglial cells [48], and dominant mutations in these genes affect microglial function by promoting neuroinflammation via activation of microglia and inflammatory signaling pathways [49–51].